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Abstract 
HCI markers are those signals created during human-computer interaction (HCI) which might provide 
information about the cognitive, mental, psychological or physiological state of the user. This 
conceptual paper presents the concept of HCI markers and makes the analogy between these markers 
and biomarkers, which are used in medicine to identify the possibility of unusual physiological 
conditions such as cancer. It then suggests a list of variables that have been reported in the literature 
and which might potentially fill the role of HCI markers. It suggests a course of study to systematically 
identify these markers, and discusses the risks associated with the HCI marker approach. It emphasizes 
the extensive multidisciplinary and interdisciplinary work that is required to achieve the goal of making 








Users who interact with information systems create a constant stream of data. The data are created 
through keyboards and pointing devices (computer mouse, touch screen, etc.), as well as via other 
sensors such as cameras, microphones and GPS receivers. This paper suggests that this stream of data 
has value which is beyond the immediate utilitarian purposes of the interaction, and that analyzing this 
stream could provide information about the health of the users. It presents research findings which link 
specific variables related to human-computer interaction (HCI) with specific cognitive, mental and 
psychological states of the users, and suggests that these and other yet unstudied variables can be used 
in a manner similar to the use of biomarkers.  
Biomarkers are “physical, functional or biochemical indicators of physiological or disease processes. 
These key indicators can provide vital information in determining disease prognosis, in predicting of 
response to therapies, adverse events and drug interactions, and in establishing baseline risk.” (Future 
Medicine, 2011). Biomarkers have been linked to various conditions such as cancer, Alzheimer’s 
disease (AD), metabolic disorders, stress, and cardiovascular disease (Diamandis, 2010; Foundation for 
the National Institutes of Health, 2011; Gerszten & Wang, 2008; Hellhammer, Wüst, & Kudielka, 
2009). Like other binary classification measures, the challenge in biomarker research is to optimize both 
the sensitivity of the assay, as well as its specificity (e.g. Nickolas, et al., 2008; Perkins & Schisterman, 
2006).  
In this conceptual paper I show that several variables related to HCI have already been linked to specific 
cognitive, mental and psychological variables. I suggest that these preliminary findings imply that it 
would be possible to identify HCI related variables which are associated with important health-related 
conditions. I then suggest several research trajectories to explore these possibilities, and discuss the 
pitfalls which need to be taken into account in such research and in the implementation of its findings.  
2. HCI MARKERS 
2.1 HCI markers and neurodegeneration 
A host of variables that might serve as HCI markers have been reported in the literature so far. Many of 
them have to do with neurodegeneration, since neurodegeneration often influences areas in the brain 
which are involved in language production. For example, in a paper titled “cognitive archaeology” 
Garrard (2009) discusses several retrospective studies of language decline in written texts and in 
transcribed spoken language samples. These texts were produced by people who were later diagnosed 
with slowly progressive dementias. These studies are described below.  
In a longitudinal study of members of the School Sisters of Notre Dame religious congregation, 
Snowdon et al. (1996) analyzed autobiographies written by the nuns when they joined the order in the 
1930’s and 1940’s. They compared the linguistic characteristics of each early autobiography with the 
present day performance of the nun in cognitive tests. The analysis showed that low idea density and 
low grammatical complexity in those early autobiographies were associated with low cognitive test 
scores dozens of years later. More specific to neurodegeneration, they also showed that of the 14 nuns 
who died by the time the study was conducted, all five who had neuropathologically confirmed AD had 
low idea density in their early biographies, compared with none of those without neuropathologically 
confirmed AD. When autobiographies of 11 more nuns from other convents who were 
neuropathologically evaluated were similarly examined, similar results were obtained. In total, in the 
cohort of 25 nuns, 90% of those with AD showed low idea density in texts written in their early life, 
compared with 13% in those without AD.  
In a study of the impact of AD on the written language of a single author whose AD was confirmed 
post-mortem (Garrard, 2008; Garrard, Maloney, Hodges, & Patterson, 2005), a comparison was made 
between early works by the celebrated writer Iris Murdoch (IM), and her latest novel, Jackson’s 
Dilemma. The novels were not edited. Based on the fact that AD reduces syntactic complexity and 
lexical richness, three of IM’s books were analyzed: an early one written in 1954 (Under the Net), The 
Sea, The Sea, written at the peak of her career (1978), and Jackson’s Dilemma, written during the early 
stages of her AD. The analysis detected several quantitative measures marking the impact of early AD 
on lexical properties of the written language: the vocabulary became less varied (decreased type-to-
token ratio) and included more frequent words.  
Another such retrospective study was carried out by Brian Butterworth, who studied the language used 
by former US President Ronald Reagan  during his debates with Walter Mondale in 1984, and 
comparing it to the language used by Reagan four years earlier (Forbes-McKay & Venneri, 2005; 
Garrard, 2009). He detected an increased rate of errors in content and in syntax, as well as abnormally 
long word-finding pauses. Ten years later, in 1994, Reagan was diagnosed with AD. Attempts to 
perform a similar retrospective study of speeches made by another politician, the British Prime Minister 
Harold Wilson, also showed marked differences in his language prior to his sudden resignation in early 
1976. The reason for the resignation was probably Wilson’s awareness of cognitive changes associated 
with the preclinical phase of a progressive degenerative dementia, probably AD (Garrard, 2009; Gomez, 
2010).  
2.2 HCI markers and emotion 
HCI markers can also be used to identify changing emotional states. A good example is work performed 
by Pennebaker, Mehl and colleagues in relation to the shock experienced by Americans following the 
September 11, 2001 attacks (Cohn, Mehl, & Pennebaker, 2004; Liehr, Mehl, Summers, & Pennebaker, 
2004). The markers in these cases were based on the vocabulary used by the study population. Their 
vocabulary was analyzed using the text analysis program Linguistic Inquiry and Word Count (LIWC: 
Pennebaker, Mehl, & Niederhoffer, 2003). LIWC checks the vocabulary used in a document against an 
internal dictionary of words and word stems which have been assigned to specific linguistic categories.  
In the Cohn et al. study, over 70,000 blog entries spanning the September 11 events were analyzed for 
words indicating emotional positivity, cognitive processing, social orientation and psychological 
distancing, as well as for words indicating preoccupation with the September 11 attacks. The results 
show the expression of more negative emotions immediately following the attacks, as well as increased 
social and cognitive engagement, and increased psychological distancing. The effect on psychological 
distancing was shown to last longer, while other effects, such as emotional positivity, returned to 
baseline within a short period of time.  
2.3 Additional HCI markers 
Language can also reflect other variables such as personality traits, and level of interpersonal trust 
(Kalman, Scissors, & Gergle, 2010; Mairesse, Walker, Mehl, & Moore, 2007). There are preliminary 
findings that identify individual differences between users based on their keystroke behavior (Epp, 
Lippold, & Mandryk, 2011; Khanna & Sasikumar, 2010; Rao, 2005). As these and other studies show 
(Castellano, Kessous, & Caridakis, 2008), more variables can provide more precise information, and 
thus it is valuable to move beyond signals created solely via the keyboard, and include signals that can 
be collected via microphones, cameras and pointing devices. This allows the inclusion of variables such 
as facial expressions, vocal pitch and intensity, variables which can provide detailed information that 
can be analyzed to teach us about fleeting, as well as more stable emotional states of the users (Cowie, 
et al., 2001).  
This section reviewed published work on only several human traits such as personality, cognitive ability 
and emotion. These traits are, of themselves, of medical importance, and as we have seen in the 
examples relating to AD, can reflect individual changes of significant medical importance. However, the 
significance of these examples goes beyond the obvious suggestion already made by some of the 
researchers, to use these markers to monitor for signs of changes such as cognitive deterioration. The 
significance of the examples lies in their demonstration that signals created during HCI can reflect 
fundamental attributes of the users. This suggests that such variables might also reflect many other 
attributes that have not yet been studied, and that some of these might be of medical relevance. What 
might these be? 
If user emotion and personality are reflected in the variables created during HCI, it might be possible to 
identify HCI markers for mental illness. Preliminary steps in this direction have been described in a 
study of language in messages posted to a bipolar disorder chatroom (Kramer, Fussell, & Setlock, 
2004). Or, if an illness such as glaucoma leads to a deterioration in eye-hand coordination (Kotecha, 
O'Leary, Melmoth, Grant, & Crabb, 2009), could this decreased coordination influence the usage of 
pointing devices such as a computer mouse? Also, could measuring mouse movements lead to an earlier 
diagnosis of tremor that might be associated with Parkinson’s disease or other medical conditions such 
as essential tremor (Shahed & Jankovic, 2007)? These are only a few speculative suggestions, but the 
potential of linking HCI markers with medically important conditions is great.  
3 IDENTIFYING  HCI MARKERS: TOP DOWN AND BOTTOM UP 
The previous section described several HCI marker candidates, based on research carried out in the last 
two decades. The challenge this section tackles is what systematic research could be suggested that 
would identify informative HCI markers which are reliable and valid enough for medical purposes.  
One bottom up approach is based on large cohorts of essentially healthy participants who will be 
recruited into the study, and agree that their interactions with their various digital devices (desktops, 
laptops and mobile devices such as cell phones and tablet computers) be recorded over a period of years. 
These longitudinal records will then be periodically analyzed and compared with the changes in the 
medical status of the study participants. Correlations between changes in specific markers and the 
development of medical conditions will be identified and compared to unaffected controls, and their 
reliability and validity evaluated. Such bottom up approaches are usually based on extensive data 
mining techniques to analyze very large datasets (e.g. Ghazavi & Liao, 2008; Klee, 2008; Rhodes, et al., 
2004).  
A top down approach would examine specific medical conditions and try to predict, based on the 
etiology and symptoms of each condition, which HCI markers might be correlated with it. Then, 
archival records of online interactions by patients who have this condition will be examined for these 
markers. Such archival records could include personal correspondence such as email or IM, as well as 
more public documents such as blogs and micro-blog postings. The work on AD described above (e.g. 
Garrard, 2009; Gomez, 2010) is a good example of this approach in which the researchers examine 
linguistic characteristics which are associated with AD, and examine ways to detect changes in these 
characteristics in archived datasets. 
The main drawback of the bottom up approach suggested here is that it is lengthy, and requires a large 
cohort of participants. Consequently, it will require extensive financial and human resources, and usable 
findings will emerge slowly. The main drawbacks of the top down approach suggested here is that 
archival records might be difficult to acquire, that these records include only a subset of the data created 
during HCI (for example typing speed and mouse movements are not captured in archived email 
messages), and that they will still require a large cohort of controls to verify the specificity of the 
putative marker. Given these drawbacks, a recommended approach would combine both ad-hoc top 
down work, with a more systematic long term bottom up longitudinal study. The longitudinal study 
might also include participants who already have medical conditions of interest. The interim findings of 
the bottom up research can be used to fine tune the top down studies, as well as to provide reference 
data in lieu of separate control cohorts for each of the top down studies.  
4 DATA COLLECTION 
This section discusses the opportunities and challenges faced by researchers who wish to collect the data 
required for the extraction of HCI markers. This discussion focuses on the collection of digital HCI data 
for the purpose of monitoring users for unusual trends in HCI markers that have already been identified. 
Similar principles apply to collecting data from research subjects for the purpose of identifying novel 
markers.  
Unlike most current research on HCI markers which focused on retrospective collection of archived 
data, i.e. of the final product (blog post, novel, transcript of IM-based conversation), our goal in the 
future should be to collect all data related to the production of that final product, as well as any 
additional information created while interacting with the digital device. For example, blog posts or 
email messages contain little information beyond the actual content of the message. On the other hand, a 
log of the keystrokes that were used to create the post or the message (Sullivan & Lindgren, 2006) can 
teach us about the chronemic variables associated with the production of the message (e.g. typing speed, 
pauses during the typing) as well as about revisions of wording, spelling or page layout. 
Information about the production process that led to the messages is important not only as a source of 
HCI markers. It also provides information about the context of the interaction that is taking place. For 
example, keystroke logging can provide information about the usage of spelling and grammar checkers;   
GPS sensors can provide information about whether the message was produced at home or at work, or 
while walking down a busy street; and, microphones can monitor the audio ambience in which the user 
is immersed. All of these contextual elements can assist in interpreting the data stream more effectively.  
Which devices can be used for monitoring HCI markers? In principle, any device with which users 
interact and which produces digital output that could be collected and archived is a candidate. The 
obvious candidates are workstations and portable computers, as well as mobile devices such as cell 
phones, smart phones, and tablet computers. Less obvious candidates are mobile and wearable devices 
such as audio and video players (e.g. iPod), e-readers (e.g. Kindle), gaming platforms (e.g. Kinect) 
head-mounted displays, or electronic textiles (Barfield & Caudell, 2001). Early lessons can be learned 
about the ability of such systems to collect and analyze data about the user in the emerging field of 
wearable physiological monitoring devices (e.g. Otto, Milenkovic, Sanders, & Jovanov, 2006; Pandian, 
et al., 2008; Wu, et al., 2008). Unlike these wearable physiological monitoring devices which are 
focused on the moment to moment monitoring of vital signs, it is expected that, at least in the short and 
medium term, HCI markers will only be used for detecting long term trends that impact health on a 
scale of weeks, months and years.  
Although the collection of data is carried out at the level of the individual, the findings could be 
aggregated to study groups of people or even whole populations, in order to increase our understanding 
of the development of specific conditions in individuals as well as population-wide processes (e.g. 
Brownstein, Freifeld, & Madoff, 2009; Cohn, et al., 2004; Liehr, et al., 2004). 
5 USING THE RESULTS 
In what way could HCI markers contribute to healthcare? The first and most obvious use is for 
diagnostic purposes: to identify a change in behaviour that is sensed through HCI and which might 
indicate the early stages of illness. Since the markers can be monitored in an unobtrusive manner, and 
since the analysis of the data is not expected to be expensive, these markers can complement periodic 
medical checkups and possibly even be evaluated in conjunction with the medical data which is used in 
those check-up appointments. It is possible to envision a future at which HCI data analysis is as routine 
as a blood or urine test, and as simple as a blood pressure measurement.   
Early detection is one of the more attractive advantages of HCI markers, since the data stream is created 
on a daily basis, and can be analyzed as often as necessary. One criticism of early detection arises in the 
case of conditions which, at present, cannot be treated (e.g. AD) or conditions in which the impact of 
early detection on eventual mortality, morbity and quality of life is controversial (e.g. prostate cancer: 
Bartsch, et al., 2008; Wolf, et al.). Despite these controversies regarding the value of population-wide 
screening, detection of pre-symptomatic and early stage patients is critical for research purposes and for 
the evaluation of experimental treatments. Without the ability to detect the earliest possible stages of the 
progression of a condition, it is significantly more difficult to evaluate treatments that might halt or slow 
the progression of a disease. Since some sectors of the population interact with computers extensively 
(Pew Research Center, 2010) these sectors produce a very large amount of data on a daily basis. These 
extensive datasets could turn out to be highly sensitive to the behavioural changes that signal the onset 
of conditions which are currently impossible or difficult to detect, or which require to proactively ask 
for a test to be carried out.    
There are many other possible uses of HCI markers. Like other biomarkers, they can also assist in 
predicting the response to therapies and in monitoring these responses, as well as in establishing 
baseline risk (Future Medicine, 2011). One relatively unusual property of HCI markers is related to the 
fact that HCI data can be archived for a long period of time. For example, many users of web-based 
email services such as gmail and Yahoo! Mail can use gigabytes of storage to archive their emails. This 
means that HCI markers can be used as a “time machine” which allows collecting pre-diagnostic 
behavioural data after a diagnosis of an illness occurs. Such a retrospective study can inform medical 
personnel about the early and sometimes even “pre-symptomatic” stages of the condition. This 
information could be used for research purposes, as well as to better understand the patient’s own 
condition and its evolution.  
It is interesting to note that datasets collected for the purpose of identifying HCI markers can also be 
used for other HCI studies. Specifically, they can be used to allow better customization of interfaces to 
user needs, and specifically to the needs of users with relevant health conditions. 
6 LIMITATIONS AND RISKS 
HCI markers have the potential to provide rich information similar to that provided by ubiquitous 
standardized medical tests such as blood or urine tests. It is relatively inexpensive to collect, and since 
all data are already digitized, there is no need for expensive transcription or digitization costs. The 
development of effective automated analysis tools will facilitate the creation of an end-to-end digital 
process that requires minimal human intervention, only at junctures that involve decision-making. This 
analysis can either be carried out in real time (for an example of real time analysis of such data see 
Leshed, et al., 2009), or at predetermined intervals, in batch mode. The ease of collection and analysis 
of ubiquitous digital data is also at the heart of the key risks associated with the proposal to use HCI 
markers for medical purposes. These include risks associated with reliability and validity, and risks 
associated with privacy and security.  
Like other biomarkers and health-related variables, HCI markers too have limited reliability and validity 
(Diamandis, 2010), which have to be carefully assessed before the markers are implemented. It is not 
expected that it would be difficult to identify HCI-related variables that correlate with the progression of 
specific conditions. The challenge would be to ascertain the extent to which these changes are specific 
to the condition. For example, we expect many HCI-related variables to change with aging, and the 
challenge would be to distinguish between these naturally occurring changes, and changes associated 
with a specific illness. Variability in the HCI-related variables will result not only from long term 
processes such as aging. As already demonstrated, these variables are influenced by ephemeral states 
such as moods, and the question is whether the naturally occurring variability will not mask the changes 
we expect HCI markers to detect. Another challenge is specificity: like body temperature or blood 
pressure, some of the important HCI markers will probably not be specific to one condition, but rather 
flag a circumstance which requires further evaluation. These reliability and validity issues are an 
important risk of the HCI-marker approach since, unlike lab tests which require highly specialized 
equipment, analysis of digital data created during HCI can be performed by almost any advanced PC 
user, and freely available online applications can even widen the circle of potential (ab)users of these 
markers. The risks associated with wide and essentially unsupervised analysis of such markers are 
exemplified by the significant ethical and medical challenges caused by the rising availability of direct-
to-consumer genetic testing (Hudson, Javitt, Burke, & Byers, 2007; Patch, Sequeiros, & Cornel, 2009).  
The collection of HCI data requires the monitoring and collection of large amounts of private 
information. Careful attention needs to be paid to ensure that this does not negatively impact the privacy 
and security of study participants and of future adopters of this approach. Here too we can learn from 
experience gained in the field of genetic analysis, where the ability to sequence whole genomes opened 
a host of new ethical challenges for researchers, as well as for practitioners (McGuire, Caulfield, & Cho, 
2008). Ethical and legal issues will need to be carefully considered when collecting, storing, analyzing, 
and using the analysis results. These will need to be translated into clear informed consent procedures 
that will ensure that participants understand the risks associated, and consider those risks acceptable. 
More specifically, since the same variables that characterize the individual and that are HCI marker 
candidates could also serve as biometric variables that identify the individual to secured systems (e.g. 
Rao, 2005), special attention needs to be paid to this intersection of privacy and security (e.g. Kerr, 
Steeves, & Lucock, 2009; McGuire, et al., 2008).  
Another privacy related concern raised by the prospect of HCI markers is the ability to analyze data 
produced by users without their permission. If blog posts, email messages, status updates, and other 
forms of public and semi-public online communication would turn out to reveal medically sensitive 
information, then it might be possible to take archives of such messages and learn about the cognitive, 
mental, psychological or physiological state of the user. Do people have a right to prevent others from 
performing this analysis or from using the results? Some aspects of these dilemmas are similar to those 
encountered in regards to rights associated with the extraction and analysis of DNA samples (Berson, 
2009; Michael, 2010; Nerko, 2008), but in essence this is a new and complex question which should be 
considered before the capability to perform such analysis becomes a widespread reality. 
7  CONCLUSION 
This conceptual paper presents and discusses the concept of HCI markers, analogous to biomarkers used 
in medical fields. After a review of studies that have demonstrated associations between these markers 
and changes in emotional, cognitive and psychological states, it is suggested that HCI markers could be 
an unobtrusive, low cost, and powerful tool to detect and track conditions of medical importance. The 
potential power and relative simplicity and low cost of this tool also raise significant concerns about 
misuse and abuse of this approach, and the threats to privacy and to security are discussed. Some 
lessons can be learned from the past in regards to similar issues related to other markers (e.g. genetic 
markers) and other illnesses (e.g. cancer and AD), but there are also significant novel risks associated 
with this approach that have not been encountered in the past. 
The promise of HCI markers is great, but it will only be fully realized through carefully controlled 
longitudinal studies in the general population, as well as studies of these markers in carefully selected 
populations with diagnosed emotional, cognitive, psychological or physiological conditions, and by 
diligent attention to the social and psychological risks associated with the collection, analysis, and 
decision making processes that will be developed. These will require multidisciplinary and 
interdisciplinary approaches that include, in addition to the already multidisciplinary approach of HCI, 
professionals from the life and medical sciences, from social and behavioural sciences, and from the 
humanities.  
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